Trial Details

COMPLETED
Basic Information
Clinical ID c1225
Identifier NCT00643071
Trial Title Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Tacrolimus
Participant Information
Sponsor Astellas Pharma Inc
City Chubu
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-09-06
Primary Completion Date 2025-05-08
Completion Date 2025-05-08